VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-)-CARVONE, (+)-CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT
THE PRESENT INVENTION CONCERNS AN ANTIVIRAL COMPOSITION COMPRISING THE FOLLOWING COMPONENTS: R-(-)-2-METHYL-5-(PROP-1-EN-2-YL)-CYCLOHEX-2-ENONE (ALSO CALLED (-) CARVONE) AND S-(+)-2-METHYL- 5-(PROP-1-EN-2-YL)-CYCLOHEX-2-ENONE (ALSO CALLED (+) CARVONE) AND (2E)- 3,7-DIMETHYLOCTA-2,6-DIEN-1-OL (ALSO CALLED TRANS-GERANIOL) IN COMBINATION WITH AT LEAST ONE MORE COMPONENT CHOSEN AMONG ESSENTIAL OILS COMPONENTS FOR USE IN TREATMENT AND PREVENTION OF DISEASES CAUSED BY DNA ENVELOPED VIRUSES, DNA NON-ENVELOPED VIRUSES, RNA ENVELOPED VIRUSES AND RNA NON-ENVELOPED VIRUSES.
